Compound ID | 304
Class: Membrane-active agent (chalcone)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Cell membrane modulators by interfering with fumarate reductase; besides being antimalarial, it has been tested on S. aureus |
| Institute where first reported: | LICA Pharmaceuticals, Denmark; Walter Reed Army Institute of Research, USA |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |